Not finding it? Sign in to also search OpenAlex live.
-
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring
Anne M.R. Schrader, Ruben A. L. de Groen, Rein Willemze, Patty M. Jansen, Koen D. Quint, Arjen Cleven, +12 more
16citations -
Assessment of malaria transmission intensity and insecticide resistance mechanisms in three rural areas of the Moyen Ogooué Province of Gabon
Stravensky Térence Boussougou-Sambe, Tamirat Gebru Woldearegai, Ange Gatien Doumba-Ndalembouly, Barclaye Ngossanga, Romuald Beh, Jean Ronald Edoa, +8 more
13citations -
Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin2021 Investigative Ophthalmology & Visual Science article Medicine Ocular Oncology and Treatments Open access
Niels J. Brouwer, Eleni K. Konstantinou, Evangelos S. Gragoudas, Marina Marinkovic, Gregorius P. M. Luyten, Ivana K. Kim, +2 more
37citations -
Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients
Marius Bill, Jan‐Niklas Eckardt, Christian R. Rausch, Klaus Hans Metzeler, Karsten Spiekermann, Sebastian Stasik, +34 more
3citations -
The Combination of Asciminib with ATP Competing Tyrosine Kinase Inhibitors Might Overcome the Negative Impact of ASXL1 Mutations on Molecular Response in Newly Diagnosed CML Patients
Jenny Rinke, Philipp le Coutre, Martina Margrit Crysandt, Tim H. Brümmendorf, Andreas Burchert, Fabian Lang, +5 more
6citations -
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
Johannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, Jan Moritz Middeke, Niels Smedegaard Andersen, Christopher Paul Fox, +12 more
5citations -
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials2024 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Paul Jank, Thomas Karn, Marion van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, +18 more
13citations -
Should the European Leukemia Net 2022 Adverse Risk Classification of NPM1 mutated Acute Myeloid Leukemia be Revisited? Among Adverse Risk Cytogenetics, Solely Complex Karyotype Is Associated with Worse Post-Transplant Survival: A Study from the EBMT Acute Leukemia Working Party
Nour M. Moukalled, Myriam Labopin, Jurjen Versluis, Gèrard Socié, Didier Blaise, Urpu Salmenniemi, +12 more
0citations -
External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium2024 Clinical Chemistry article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access
Paul van der Leest, Pim Rozendal, John W. J. Hinrichs, Carel J.M. van Noesel, Karen Zwaenepoel, Birgit A. L. M. Deiman, +14 more
10citations -
Early [18F]FDG PET/CT response evaluation after a single dose of anti-EGFR therapy as a predictive biomarker for treatment benefit in patients with advanced colorectal cancer.2024 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Treatments and Studies
Catharina Wilhelmina Menke, Sophie L. Gerritse, Erik Jacobus Van Helden, Anne I.J. Arens, Ronald Boellaard, Tineke E. Buffart, +8 more
0citations -
Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
0citations